|
⚲
|
| Keyboard |
| McKechnie Duncan
✚
|
|
|---|---|
| CIK # | 0002062139 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002062139] | |
| 4 | [0002062139] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| McKechnie Duncan | |
| Vertex Pharmaceuticals Inc / Ma |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-03-11 | Sell | 2,633 | $498.42 | 1,312,340 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-03-04 | Sell | 2,437 | $475.30 | 1,158,306 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-25 | Sell | 2,500 | $486.35 | 1,215,875 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-25 | Sell | 2,410 | $489.00 | 1,178,490 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-24 | Tax withheld | 873 | $485.11 | 423,501 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-17 | Grant | 4,962 | $0.00 | |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-17 | Tax withheld | 1,148 | $483.75 | 555,345 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-13 | Tax withheld | 2,283 | $487.76 | 1,113,556 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-10 | Tax withheld | 1,127 | $468.41 | 527,898 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-01-22 | Grant | 2,080 | $0.00 | |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-01-22 | Grant | 4,720 | $0.00 |